Cabaletta Bio, Inc. — Director's Dealing 2019

Oct 25, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2019-10-24

Reporting Person: Bollard Catherine (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.30	2029-03-27	Common Stock (46428)		Direct

Footnotes

F1: This option vests in eight equal quarterly installments beginning on March 28, 2019.